bapineuzamab

Showing 1 posts of 1 posts found.

lamattina_web

John LaMattina: Why was bapineuzamab moved into Phase III trials?

September 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, John LaMattina, Pfizer, bapineuzamab

The recent news that the Pfizer/J&J Alzheimer’s Disease drug, bapineuzumab (bapi), had failed in critical clinical trials resulted in great …

The Gateway to Local Adoption Series

Latest content